Georgia [US], November 12 (ANI): New research on the prevalence and risk factors for new-onset interstitial lung disease (ILD) among individuals with systemic sclerosis who previously tested negative for ILD. Research was presented at ACR Convergence 2023, the annual conference of the American College of Rheumatology (ACR). One of the…Read More
More insight into risk factors for newonset interstitial lung disease in systemic sclerosis
